---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-007187"
form_type: "8-K"
ticker: "AIFF"
cik: "0000803578"
company_name: "FIREFLY NEUROSCIENCE, INC."
filed_at: "2024-03-08T23:59:59+00:00"
generated_at: "2026-06-05T00:57:17.092807+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Firefly white paper shows BNA platform boosts MDD treatment compliance 15%, cuts med switches >50%

## Summary
- Analysis of 2,253 patients at a U.S. psychiatric clinic using Firefly’s BNA Platform.
- MDD treatment adherence rose 15%; need for antidepressant switches fell >50%.
- Patients with MDD, GAD, ADHD saw >2x improvement in general functioning.
- Antidepressant response rates increased 10%; non-responder rate fell 17%.
- Results support Firefly’s planned merger with WaveDancer (WAVD); shareholder vote set for March 14.

## SEC filing metadata
- accession: 0001437749-24-007187
- form_type: 8-K
- ticker: AIFF
- cik: 0000803578
- company_name: FIREFLY NEUROSCIENCE, INC.
- filed_at: 2024-03-08T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/803578/000143774924007187/0001437749-24-007187-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/803578/000143774924007187/wavd20240308_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-007187
- JSON: https://secwatch.observer/filing/0001437749-24-007187.json
- Plain text: https://secwatch.observer/filing/0001437749-24-007187.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.